Read
- Taxes on some wealthy French top 100 pct of income: paper
- North Korea fires short-range missiles for two days in a row
|
- Israel warns against Russian arms supply to Syria
- Winning ticket for $590.5 million Powerball lottery sold in Florida
|
- Toyota plans to increase lithium-ion car battery output-Nikkei
Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Ethiopia's salt trails
For centuries merchants have traveled to Ethiopia to collect salt from the surface of the vast desert basin. Slideshow
Sponsored Links
Novo Nordisk says Victoza superior to Amylin rival
COPENHAGEN |
COPENHAGEN (Reuters) - Denmark's Novo Nordisk, the world's biggest insulin producer, said on Monday a study had confirmed its diabetes drug Victoza provided greater reductions in blood sugar levels than rival drug Byetta from Amylin.
Novo Nordisk said in a statement the study, presented at the 72nd Annual Scientific Sessions of the ADA in Philadelphia, showed more patients appeared to favor a drug given by injection over a drug which is given orally.
The study also confirmed weight loss and cost-effectiveness in the use of Victoza, Novo Nordisk said.
(Reporting by Copenhagen Newsroom; Editing by Mark Potter)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters